Granulocyte –macrophage colony‐stimulating factor (GM‐CSF) as a therapeutic target in psoriasis: randomized, controlled investigation using namilumab, a specific human anti‐GM‐CSF monoclonal antibody

British Journal of Dermatology, EarlyView.

Source: British Journal of Dermatology - November 2, 2018 Category: Dermatology Authors: K.A. Papp, M. Gooderham, R. Jenkins, R. Vender, J.C. Szepietowski, T. Wagner, B. Hunt, B. Souberbielle, on behalf of the NEPTUNE investigators Source Type: research